Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Arcadia Biosciences, Inc. (17D.F) Follow Compare 3.7200 0.0000 (0.00%) As of February 24 at 8:06:54 AM GMT+1. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations M&S Clothing & Home shakeup sees former Boohoo boss Lyttle join team British High Street giant Marks & Spencer (M&S) has appointed former-Boohoo boss John Lyttle to lead its clothing, home, and beauty divisions as the company moves ahead with the next phase of transformation for future growth. Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105% RKDA inks deal with Roosevelt to become a new entity, Roosevelt Resources, with Roosevelt as the majority shareholder. Arcadia Biosciences Merges with Roosevelt Resources Arcadia Biosciences ( (RKDA) ) has issued an announcement. Arcadia Biosciences and Roosevelt Resources have agreed to merge in an all-stock deal, making Roosevelt the majority shareholder. This strategic move aims to capitalize on Roosevelt’s vast oil and gas assets, particularly its carbon capture and storage project in Texas. The merger promises to enhance shareholder value and streamline operations, with Roosevelt’s experienced management leading the combined entity. The transaction is expect Arcadia Biosciences to Combine With Roosevelt Resources; Shares Surge Pre-Bell Arcadia Biosciences (RKDA) shares were up more than 209% in recent Thursday premarket activity follo Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction DALLAS, December 05, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA) and Roosevelt Resources LP announced today that they have entered into a definitive securities exchange agreement which, when completed, will combine the two companies in an all-stock transaction. Under the terms of the agreement, Arcadia will issue to the partners of Roosevelt shares of Arcadia common stock at the closing of the transaction in exchange for all of the equity interests in Roosevelt. Following the closing of the Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand. Arcadia Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags Arcadia Biosciences ( NASDAQ:RKDA ) Third Quarter 2024 Results Key Financial Results Revenue: US$1.54m (down 3.8% from... GrowGeneration Earnings Miss Estimates in Q3, Revenues Dip Y/Y GRWG expects revenues between $190 million and $195 million for 2024. Q3 2024 Arcadia Biosciences Inc Earnings Call Q3 2024 Arcadia Biosciences Inc Earnings Call Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... Arcadia Biosciences Inc (RKDA) reports an 18% revenue increase driven by Zola coconut water sales, while navigating increased expenses and strategic uncertainties. Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -12.99% and 9.94%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? Arcadia Biosciences: Q3 Earnings Snapshot DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Tuesday reported a loss of $1.6 million in its third quarter. On a per-share basis, the Dallas-based company said it had a loss of $1.18. Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights DALLAS, November 12, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter and first nine months of 2024. Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call DALLAS, October 29, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2024 after market close on November 12, 2024. Zacks Industry Outlook Highlights Bunge, West Fraser Timber, Hydrofarm and Arcadia Biosciences Bunge, West Fraser Timber, Hydrofarm and Arcadia Biosciences have been highlighted in this Industry Outlook article. 4 Agriculture - Products Stocks to Watch Despite Industry Concerns The near-term outlook for the Zacks Agriculture - Products industry is uncertain due to low commodity prices and inflated costs. Investors should watch BG, WFG, HYFM and RKDA, which are braving the industry headwinds. Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains. Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -38.58% and 37.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? Arcadia Biosciences: Q2 Earnings Snapshot DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Tuesday reported profit of $1.1 million in its second quarter. The Dallas-based company said it had net income of 78 cents per share. Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights DALLAS, August 13, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2024. Performance Overview Trailing total returns as of 2/27/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return 17D.F S&P 500 YTD -34.74% +1.17% 1-Year +41.98% +17.17% 3-Year -88.08% +35.71%